RET9 (RET or CDHF12 or CDHR16) Antibody - FFPE Validated

About the Target

This antibody supports efforts to evaluate RET9 (CDHF12) and interpret it within interaction networks. RET9 is a regulator within kinase-driven cascades that influence transcriptional and metabolic responses. Many projects interpret this target alongside interacting partners, upstream cues, and downstream readouts.

In some datasets and protocols, it is referenced by the gene symbol CDHF12.

Research Context

Parallel measurement of upstream inputs and downstream readouts can sharpen interpretation of pathway behavior. Considering complex membership and compartment shifts can clarify whether changes reflect signaling or redistribution. Developmental projects may follow this target across stage-dependent remodeling and tissue patterning.

Consider these angles when interpreting target-level changes:

• condition-to-condition comparisons with matched controls
• interaction patterns within multi-protein complexes
• time-resolved changes following stimulation or inhibition

Variant Considerations

This fixed-section oriented version is intended for paraffin-embedded tissue, where crosslinking and retrieval steps can shape epitope accessibility. This matters because epitope exposure and background can vary with preparation and extraction steps. If you compare conditions, keep processing steps uniform to support clean interpretation.

To support downstream analysis, record key context variables (culture timing, stimulation window, and extraction approach) so RET9 patterns can be compared across experiments without guesswork.

For challenging targets, pairing RET9 measurements with a second marker can clarify whether differences arise from regulation, redistribution, or shifts in cell composition within the sample.

Use the fixed-section version to relate RET9 (CDHF12) behavior to upstream cues and downstream consequences.